Nath Bio-Genes Schedules Q2 & H1FY27 Earnings Conference Call for 16th Nov'26
Nath Bio-Genes (India) Ltd 路 Intimation 路 16 Nov 2026, 4:00 pm
Nath Bio-Genes Schedules Q2 & H1FY27 Earnings Conference Call for 16th Nov'26 Nath Bio-Genes (India) Limited will host its Q2 & H1FY27 earnings conference call on 16th Nov'26 at 04:00 PM IST, hosted by Go India Advisors. Senior management, including Managing Director Satish Kagliwal, Executive Vice President Dr. Devinder Khurana, Chief Financial Officer Amol Gupta, Sales Lead Harish Pandey, and Research Lead Venkatesh Kulkarni, will participate to discuss operational and financial performance. Universal dial-in numbers include 086 3416 8887 and 086 4536 7331.
Original exchange filing (PDF)
More announcements from Nath Bio-Genes (India) Ltd
- Audio Transcript of Conference Call held on 16th November 2026 路 17 Nov 2026
- Presentation on Unaudited Financial Results as of 30th September 2026 路 16 Nov 2026
- Nath Bio-Genes (India) Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 14 Nov 2026
- Unaudited Standalone and Consolidated Financial Results as on 30th September 2026 路 14 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 14 Nov 2026
- NATH BIO-GENES (INDIA) LIMITED has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 . 路 14 Nov 2026
- Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve unaudited financial .... 路 14 Nov 2026
- Proceedings of AGM and Scrutinizers report for AGM held on 24th September 2026 路 24 Sept 2026
